These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2461891)

  • 81. Serum alpha-fetoprotein levels and microheterogeneity in patients with different liver diseases.
    Nikolić JA; Stajić M; Cuperlović M; Hajduković L; Golubović G
    J Hepatol; 1990 Sep; 11(2):252-6. PubMed ID: 1701455
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
    Chen DS; Sung JL; Sheu JC; Lai MY; How SW; Hsu HC; Lee CS; Wei TC
    Gastroenterology; 1984 Jun; 86(6):1404-9. PubMed ID: 6201411
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis.
    Kumada T; Nakano S; Takeda I; Kiriyama S; Sone Y; Hayashi K; Katoh H; Endoh T; Sassa T; Satomura S
    J Hepatol; 1999 Jan; 30(1):125-30. PubMed ID: 9927159
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
    Giannini EG; Farinati F; Trevisani F
    Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475
    [No Abstract]   [Full Text] [Related]  

  • 85. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.
    Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Alpha-1-antitrypsin deficiency resulting in a hitherto unseen presentation of hepatocellular carcinoma: polycythemia but with normal alpha fetoprotein.
    Owen DR; Sivakumar R; Suh ES; Seevaratnam M
    World J Gastroenterol; 2006 Aug; 12(30):4906-7. PubMed ID: 16937479
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Early diagnosis of hepatocellular carcinoma.
    Okazaki N; Yoshino M; Yoshida T; Takayasu K; Moriyama N; Makuuchi M; Yamazaki S; Hasegawa H; Noguchi M; Hirohashi S
    Hepatogastroenterology; 1990 Oct; 37(5):480-3. PubMed ID: 1701411
    [TBL] [Abstract][Full Text] [Related]  

  • 88. S-phase cells in diseased human liver determined by an in vitro BrdU-anti-BrdU method.
    Shimizu A; Tarao K; Takemiya S; Harada M; Inoue T; Ono T
    Hepatology; 1988; 8(6):1535-9. PubMed ID: 2847968
    [TBL] [Abstract][Full Text] [Related]  

  • 89. In vivo screening of hepatocellular carcinoma using AC susceptibility of anti-alpha fetoprotein-activated magnetic nanoparticles.
    Chieh JJ; Huang KW; Lee YD; Horng HE; Yang HC; Hong CY
    PLoS One; 2012; 7(10):e46756. PubMed ID: 23056437
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks.
    Bukofzer S; Stass PM; Kew MC; de Beer M; Groeneveld HT
    Br J Cancer; 1989 Mar; 59(3):417-20. PubMed ID: 2467686
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Primary malignant hepatic tumours in childhood.
    Schmidt D; Harms D; Lang W
    Virchows Arch A Pathol Anat Histopathol; 1985; 407(4):387-405. PubMed ID: 2413614
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of α-fetoprotein.
    Zhu AX; Finn RS; Galle PR; Llovet JM; Kudo M
    Lancet Oncol; 2019 Apr; 20(4):e191. PubMed ID: 30942178
    [No Abstract]   [Full Text] [Related]  

  • 93. Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer.
    Sell S
    Tumour Biol; 2008; 29(3):161-80. PubMed ID: 18612221
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Serum vitamin B12 binders in South African blacks with hepatocellular carcinoma.
    van Tonder S; Kew MC; Hodkinson J; Metz J; Fernandes-Costa F
    Cancer; 1985 Aug; 56(4):789-92. PubMed ID: 2410092
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Ramucirumab and the controversial role of α-fetoprotein in hepatocellular carcinoma.
    Abou-Alfa GK
    Lancet Oncol; 2019 Feb; 20(2):177-179. PubMed ID: 30665868
    [No Abstract]   [Full Text] [Related]  

  • 96. Unique clinicopathological features of patients with primary malignant hepatic tumors who are seropositive for lectin-reactive alpha-fetoprotein alone: report of five cases.
    Okuda H; Saito A; Haruyama K; Hayashi N; Yamamoto M; Takasaki K; Nakano M
    J Gastroenterol Hepatol; 2004 Jan; 19(1):113-4. PubMed ID: 14675254
    [No Abstract]   [Full Text] [Related]  

  • 97. Fifty years of discovery of alpha-fetoprotein as the first tumor marker.
    Nikulina D; Terentyev A; Galimzyanov K; Jurišić V
    Srp Arh Celok Lek; 2015; 143(1-2):100-4. PubMed ID: 25845261
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Alpha-fetoprotein producing rhabdomyosarcoma of the adult liver.
    Mori H; Matsubara N; Fujii M; Kawai T; Tanaka T; Takahashi M
    Acta Pathol Jpn; 1979 May; 29(3):485-91. PubMed ID: 88164
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Letter to the Editor: Comment on Alpha-Fetoprotein Decrease From >1,000 to <500 ng/mL in Patients With Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.
    Akbulut S; Sahin TT; Yilmaz S
    Hepatology; 2020 Dec; 72(6):2242-2243. PubMed ID: 32583464
    [No Abstract]   [Full Text] [Related]  

  • 100. ASO Author Reflections: Fibrolamellar Hepatocellular Carcinoma and Alpha-Fetoprotein.
    McDonald JD; Hernandez JM
    Ann Surg Oncol; 2020 Jun; 27(6):1906-1907. PubMed ID: 32189170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.